NIH-funded research NIH-funded research

Molecular and brain circuits linked to anxiety disorders

Official title: Elucidating the molecular and neural components of the C1PAG and its contribution to Anxiety Disorders

Funded at University of Nebraska Medical Center · NIH-11598006 · Data updated 2026-11-12

A researcher is studying a specific brain circuit to understand what drives anxiety and how it could be treated for people with anxiety disorders.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center
NIH-funded
Lab location1 site (Omaha, United States)
Project startJune 1, 2026
Project endMay 31, 2030
Funding year2026
Award (this year)$270,881
NIH project number5P20GM130447-07
Project IDNIH-11598006 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with anxiety disorders who may benefit from future therapies derived from this circuit research.

Less likely to help

Current patients will not directly receive a new treatment during this grant period.

What this research studies

This project focuses on a particular group of brain cells in the brainstem that seem to trigger anxiety when activated. Using advanced genetic and imaging techniques in mice, researchers will map how these cells communicate with other brain regions and how internal body signals influence anxiety states. The work combines cutting-edge tools like single-cell RNA sequencing, spatial mapping, and calcium imaging to create a detailed map of the C1PAG circuit and its role in anxiety. The goal is to uncover targets for new treatments that could lessen anxiety and prevent its progression from acute to chronic.

Why it matters

Potential benefit: If successful, the findings could lead to new approaches for reducing anxiety symptoms by targeting specific brain circuits.

How similar studies have gone: Previous studies show that manipulating specific brain circuits can alter anxiety-related behaviors in animals, supporting the potential for translation to humans.

Where this research is happening

  • University of Nebraska Medical Center
    Omaha, United States
    Active

Researchers

  • Principal investigator: Fernández-Peña Acuña, Carlos — University of Nebraska Medical Center
  • Study coordinator: Fernández-Peña Acuña, Carlos

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.